Biological response modifiers.
Clark
J W
JW
Massachusetts General Hospital, Boston 02114, USA.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016588:Anticarcinogenic Agents / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D015316:Genetic Therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006433:Hemocyanins / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use; D009163:Mycobacterium bovis; D009369:Neoplasms / Q000628:therapy*
D000911:Antibodies, Monoclonal; D016588:Anticarcinogenic Agents; D019496:Cancer Vaccines; D007155:Immunologic Factors; D007376:Interleukin-2; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin